With its genetic database approach, LifeMine hopes to greatly speed up how long it takes to develop new fungi-derived drugs.
"It totally changes everything. You're starting with a human target, you're getting to the genes and you know what those genes do: they make a small molecule that hits that target," Verdine said."Now, it's all deterministic. We have made that work. That works." Stahl said LifeMine's approach leans on nature, rather than medicinal chemists, to design the drugs. That appealed to him after spending much of his career tinkering with drug candidates at the lab bench.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: